(Q40468601)

English

Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage.

scientific article published on February 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage. (English)

1 reference

Europe PubMed Central

20 September 2017

Richard T. Wyatt

2

object named as

Richard Wyatt

1 reference

Europe PubMed Central

20 September 2017

author name string

Marie Pancera

1

1 reference

Europe PubMed Central

20 September 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

332

1 reference

Europe PubMed Central

20 September 2017

145-156

1 reference

Europe PubMed Central

20 September 2017

1

1 reference

Europe PubMed Central

20 September 2017

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Visualization of fusion activation in the Semliki Forest virus spike.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Specific Antibody Responses to Vaccination with Bivalent CM235/SF2 gp120: Detection of Homologous and Heterologous Neutralizing Antibody to Subtype E (CRF01.AE) HIV Type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Structure and function of a paramyxovirus fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

HIV-1 antibody--debris or virion?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Effects of HIV Type 1 Envelope Glycoprotein Proteolytic Processing on Antigenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Expression, purification, and characterization of recombinant HIV gp140. The gp41 ectodomain of HIV or simian immunodeficiency virus is sufficient to maintain the retroviral envelope glycoprotein as a trimer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2004.10.042

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40468601&oldid=1537864725"